![OncLive](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/836/normal/Screen_Shot_2017-10-24_at_17.05.10.png?1508861154)
Overcoming Resistance Mutations Is a Focus for Novel Therapies in R/R CLL
OncLive,
Nicole Lamanna, MD Patients with chronic lymphocytic leukemia (CLL) are commonly treated with a covalent BTK inhibitor such as…
Nicole Lamanna, MD Patients with chronic lymphocytic leukemia (CLL) are commonly treated with a covalent BTK inhibitor such as…
Blood cancer is a deadly disease that kills one every nine minutes in the United States and diagnoses one every three minutes.
L'ESSENTIEL Les cancers du sang étudiés dans cet essai affectent un type spécifique de globules blancs, appelé lymphocyte B…
Jennifer Woyach, M.D., a hematologist and study lead investigator, notes that roughly a half-dozen medications are available to…